vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v24i5.2965vsp-3863Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEWНутрицевтики в виде БАД в лечении ожирения у детей: мифы и реальностьNutraceuticals as Dietary Supplements in the Treatment of Childhood Obesity: Myths and Realityhttps://orcid.org/0000-0001-7308-7280ХавкинА. И.KhavkinAnatoly I.

Хавкин Анатолий Ильич, доктор медицинских наук, профессор, руководитель Московского областного центра гастроэнтерологии и гепатологии им. А.В. Мазурина Научно-исследовательского клинического института; профессор кафедры Медицинского института Белгородского государственного национального исследовательского университета

115093, Москва, ул. Большая Серпуховская, д. 62

Moscow; Belgorod

gastropedclin@gmail.comhttps://orcid.org/0000-0002-4733-3262НалетовА. В.NalyotovAndrew V.

Донецк

Donetsk

https://orcid.org/0000-0003-3522-5384БыстроваВ. И.BystrovaValeria I.

Новосибирск

Novosibirsk

https://orcid.org/0009-0007-9699-233XСергеевД. А.SergeevDaniil A.

Новосибирск

Novosibirsk

https://orcid.org/0009-0008-7479-8277НовиковаМ. Ф.NovikovaMaria F.

Новосибирск

Novosibirsk

ВайманА. О.VaymanAnna O.

Новосибирск

Novosibirsk

https://orcid.org/0000-0003-3606-4068ШрайнерЕ. В.ShraynerEvgenia V.

Новосибирск

Novosibirsk,

Научно-исследовательский клинический институт детства; Белгородский государственный национальный исследовательский университетРоссияChildhood Research Institute; Belgorod State National Research UniversityRussian FederationДонецкий государственный медицинский университет им. М. ГорькогоРоссияDonetsk State Medical University named after M. GorkyRussian FederationНовосибирский государственный университет; Институт химической биологии и фундаментальной медициныРоссияNovosibirsk State University; Institute of chemical biology and fundamental medicineRussian FederationНовосибирский государственный университетРоссияNovosibirsk State UniversityRussian FederationНовосибирский государственный медицинский университетРоссияNovosibirsk State Medical UniversityRussian Federation202530112025245343352Copyright © Хавкин А.И., Налетов А.В., Быстрова В.И., Сергеев Д.А., Новикова М.Ф., Вайман А.О., Шрайнер Е.В., 20252025Хавкин А.И., Налетов А.В., Быстрова В.И., Сергеев Д.А., Новикова М.Ф., Вайман А.О., Шрайнер Е.В.Khavkin A.I., Nalyotov A.V., Bystrova V.I., Sergeev D.A., Novikova M.F., Vayman A.O., Shrayner E.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/3863

Ожирение в детском возрасте — важная медико-социальная проблема, в том числе в связи с развитием метаболических осложнений, хронического низкоинтенсивного воспаления, а также инсулинорезистентности — ключевого фактора метаболического синдрома. В этом контексте актуальным остается поиск безопасных и эффективных методов профилактики и терапии детского ожирения. Эффективность комплексной терапии ожирения может быть повышена применением нутрицевтиков — пищевых добавок с доказанным положительным влиянием на здоровье. В обзоре проанализирован широкий спектр нутрицевтиков (омега-3 полиненасыщенные жирные кислоты, пробиотики, инозитолы, берберин, дииндолилметан и др.), механизмов их действия, показателей эффективности и безопасности, особенностей применения.

Childhood obesity is crucial medical and social issue due to development of metabolic complications, chronic low-grade inflammation, and insulin resistance as the key factor of metabolic syndrome. Thus, the search of safe and effective methods for prevention and management of childhood obesity remains relevant. The efficacy of obesity complex therapy can be enhanced via nutraceuticals — dietary supplements with established positive effect on health. This review analyzes wide range of nutraceuticals (omega 3 fatty acids, probiotics, inositols, berberine, diindolylmethane, etc.), their mode of action, efficacy and safety indicators, and administration features.

ожирениецитокиныадипокинывоспалениеметаболический синдромнутрицевтикидетиobesitycytokinesadipokinesinflammationmetabolic syndromenutraceuticalschildrenОтсутствует.Not specified.ReferencesКаннер Е.В., Максимов М.Л., Каннер И.Д., Горелов А.В. Дефицит витамина D у детей с ожирением: следствие или причина? // РМЖ. Медицинское обозрение. — 2022. — Т. 6. — № 9. — С. 516-522. — doi: https://doi.org/10.32364/2587-6821-2022-6-9-516-522Kanner EV, Maksimov ML, Kanner ID, Gorelov AV. Vitamin D deficiency in children with obesity: consequence or cause? Russian Medical Inquiry. 2022;6(9):516-522. (In Russ). doi: https://doi.org/10.32364/2587-6821-2022-6-9-516-522Frithioff-Bojsoe C, Lund MAV, Lausten-Thomsen U, et al. Leptin, adiponectin, and their ratio asmarkers of insulin resistance and cardiometabolic risk in childhood obesity. Pediatr Diabetes. 2020;21(2):194-202. doi: https://doi.org/10.1111/pedi.12964Frithioff-Bojsoe C, Lund MAV, Lausten-Thomsen U, et al. Leptin, adiponectin, and their ratio asmarkers of insulin resistance and cardiometabolic risk in childhood obesity. Pediatr Diabetes. 2020;21(2):194-202. doi: https://doi.org/10.1111/pedi.12964Marcus C, Danielsson P Hagman E. Pediatric obesity-Longterm consequences and effect of weight loss. J Intern Med. 2022;292(6):870-891. doi: https://doi.org/10.1111/joim.13547Marcus C, Danielsson P Hagman E. Pediatric obesity-Longterm consequences and effect of weight loss. J Intern Med. 2022;292(6):870-891. doi: https://doi.org/10.1111/joim.13547Pkhaladze L, Barbakadze L, Kvashilava N. Myoinositol in the Treatment of Teenagers Affected by PCOS. Int J Endocrinol. 2016;2016:1473612. doi: https://doi.org/10.1155/2016/1473612Pkhaladze L, Barbakadze L, Kvashilava N. Myoinositol in the Treatment of Teenagers Affected by PCOS. Int J Endocrinol. 2016;2016:1473612. doi: https://doi.org/10.1155/2016/1473612Васюкова О.В., Окороков П.Л., Малиевский О.А. и др. Клинические рекомендации «Ожирение у детей» // Ожирение и метаболизм. — 2024. — Т. 21. — № 4. — С. 439-453. — doi: https://doi.org/10.14341/omet13194Vasyukova OV,Okorokov PL, Malievskiy OA, et al. Clinical guidelines “Obesity in children”. Obesity and metabolism. 2024;21(4):439-453. (In Russ). doi: https://doi.org/10.14341/omet13194Wu S, Zhu C, Wang Z, et al. Effects of Fish Oil Supplementation on Cardiometabolic Risk Factors in Overweight or Obese Children and Adolescents: A Meta-Analysis of Randomized Controlled Trials. Front Pediatr. 2021;9:604469. doi: https://doi.org/10.3389/fped.2021.604469Wu S, Zhu C, Wang Z, et al. Effects of Fish Oil Supplementation on Cardiometabolic Risk Factors in Overweight or Obese Children and Adolescents: A Meta-Analysis of Randomized Controlled Trials. Front Pediatr. 2021;9:604469. doi: https://doi.org/10.3389/fped.2021.604469Li Y, Liu T, Qin L, Wu L. Effects of probiotic administration on overweight or obese children: a meta-analysis and systematic review. J Transl Med. 2023;21(1):525. doi: https://doi.org/10.1186/s12967-023-04319-9Li Y, Liu T, Qin L, Wu L. Effects of probiotic administration on overweight or obese children: a meta-analysis and systematic review. J Transl Med. 2023;21(1):525. doi: https://doi.org/10.1186/s12967-023-04319-9Virgolici B, Popescu LA, Virgolici HM, et al. Effects of omega-3 fatty acids associated with antioxidant vitamins in overweight and obese children. Acta Endocrinol (Buchar). 2023;19(2):221-227. doi: https://doi.org/10.4183/aeb.2023.221Virgolici B, Popescu LA, Virgolici HM, et al. Effects of omega-3 fatty acids associated with antioxidant vitamins in overweight and obese children. Acta Endocrinol (Buchar). 2023;19(2):221-227. doi: https://doi.org/10.4183/aeb.2023.221European Food Safety Authority (EFSA). Dietary Reference Values for nutrients Summary report. EFSA Supporting Publications. 2017;14(12):23. doi: https://doi.org/10.2903/sp.efsa.2017.e15121European Food Safety Authority (EFSA). Dietary Reference Values for nutrients Summary report. EFSA Supporting Publications. 2017;14(12):23. doi: https://doi.org/10.2903/sp.efsa.2017. e15121van der Wurff ISM, Meyer BJ, de Groot RHM. Effect of Omega-3 Long Chain Polyunsaturated Fatty Acids (n-3 LCPUFA) Supplementation on Cognition in Children and Adolescents: A Systematic Literature Review with a Focus on n-3 LCPUFA Blood Values and Dose of DHA and EPA. Nutrients. 2020;12(10):3115. doi: https://doi.org/10.3390/nu12103115van der Wurff ISM, Meyer BJ, de Groot RHM. Effect of Omega-3 Long Chain Polyunsaturated Fatty Acids (n-3 LCPUFA) Supplementation on Cognition in Children and Adolescents: A Systematic Literature Review with a Focus on n-3 LCPUFA Blood Values and Dose of DHA and EPA. Nutrients. 2020;12(10):3115. doi: https://doi.org/10.3390/nu12103115Khorshidi M, Hazaveh ZS, Alimohammadi-Kamalabadi M, et al. Effect of omega-3 supplementation on lipid profile in children and adolescents: a systematic review and meta-analysis of randomized clinical trials. Nutr J. 2023;22(1):9. doi: https://doi.org/10.1186/s12937-022-00826-5Khorshidi M, Hazaveh ZS, Alimohammadi-Kamalabadi M, et al. Effect of omega-3 supplementation on lipid profile in children and adolescents: a systematic review and meta-analysis of randomized clinical trials. Nutr J. 2023;22(1):9. doi: https://doi.org/10.1186/s12937-022-00826-5Chang JP Tseng PT, Zeng BS, et al. Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr. 2023;14(6):1326-1336. doi: https://doi.org/10.1016/j.advnut.2023.08.003Chang JP Tseng PT, Zeng BS, et al. Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr. 2023;14(6):1326-1336. doi: https://doi.org/10.1016/j.advnut.2023.08.003Jones RB, Alderete TL, Martin AA, et al. Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16-week, randomized, placebo-controlled trial. Pediatr Obes. 2018;13(11):705-714. doi: https://doi.org/10.1111/ijpo.12273Jones RB, Alderete TL, Martin AA, et al. Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16-week, randomized, placebo-controlled trial. Pediatr Obes. 2018;13(11):705-714. doi: https://doi.org/10.1111/ijpo.12273Million M, Angelakis E, Paul M, et al. Comparative meta-analysis of the effect of lactobacillus species on weight gain in humans and animals. Microb Pathog. 2012;53(2):100-108. doi: https://doi.org/10.1016/j.micpath.2012.05.007Million M, Angelakis E, Paul M, et al. Comparative meta-analysis of the effect of lactobacillus species on weight gain in humans and animals. Microb Pathog. 2012;53(2):100-108. doi: https://doi.org/10.1016/j.micpath.2012.05.007Larsen N, Vogensen FK, Gobel RJ, et al. Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clin Nutr. 2013;32(6):935-940. doi: https://doi.org/10.1016/j.clnu.2013.02.007Larsen N, Vogensen FK, Gobel RJ, et al. Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clin Nutr. 2013;32(6):935-940. doi: https://doi.org/10.1016/j.clnu.2013.02.007Zalewski BM, Szajewska H. No Effect of Glucomannan on Body Weight Reduction in Children and Adolescents with Overweight and Obesity: A Randomized Controlled Trial. J Pediatr. 2019;211: 85-91.e1. doi: https://doi.org/10.1016/j.jpeds.2019.03.044Zalewski BM, Szajewska H. No Effect of Glucomannan on Body Weight Reduction in Children and Adolescents with Overweight and Obesity: A Randomized Controlled Trial. J Pediatr. 2019;211: 85-91.e1. doi: https://doi.org/10.1016/j.jpeds.2019.03.044Duan Y, Wang L, Ma Y et al. A meta-analysis of the therapeutic effect of probiotic intervention in obese or overweight adolescents. Front Endocrinol (Lausanne). 2024;15:1335810. doi: https://doi.org/10.3389/fendo.2024.1335810Duan Y, Wang L, Ma Y et al. A meta-analysis of the therapeutic effect of probiotic intervention in obese or overweight adolescents. Front Endocrinol (Lausanne). 2024;15:1335810. doi: https://doi.org/10.3389/fendo.2024.1335810Robertson C, Savva GM, Clapuci R, et al. Incidence of necrotising enterocolitis before and after introducing routine prophylactic Lactobacillus and Bifidobacterium probiotics. Arch Dis Child Fetal Neonatal Ed. 2020;105(4):F380-F386. doi: https://doi.org/10.1136/archdischild-2019-317346Robertson C, Savva GM, Clapuci R, et al. Incidence of necrotising enterocolitis before and after introducing routine prophylactic Lactobacillus and Bifidobacterium probiotics. Arch Dis Child Fetal Neonatal Ed. 2020;105(4):F380-F386. doi: https://doi.org/10.1136/archdischild-2019-317346Pkhaladze L, Russo M, Unfer V, et al. Treatment of lean PCOS teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives. Eur Rev Med Pharmacol Sci. 2021;25(23): 7476-7485. doi: https://doi.org/10.26355/eurrev_202112_27447Pkhaladze L, Russo M, Unfer V, et al. Treatment of lean PCOS teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives. Eur Rev Med Pharmacol Sci. 2021;25(23): 7476-7485. doi: https://doi.org/10.26355/eurrev_202112_27447Antoniotti V, Partenope C, Solito A, et al. Efficacy of myo-inositol and zinc on insulin resistance in a paediatric population with obesity. Diabetes Obes Metab. 2025;27(4):1932-1939. doi: https://doi.org/10.1111/dom.16185Antoniotti V, Partenope C, Solito A, et al. Efficacy of myo-inositol and zinc on insulin resistance in a paediatric population with obesity. Diabetes Obes Metab. 2025;27(4):1932-1939. doi: https://doi.org/10.1111/dom.16185Sairally BZF, Dhillon-Smith RK, Jethwani G, Latthe P Myoinositol or D-chiro-inositol for PCOS symptoms in adolescents: a narrative review. J Pediatr Endocrinol Metab. 2023;37(2):91-101. doi: https://doi.org/10.1515/jpem-2023-0458Sairally BZF, Dhillon-Smith RK, Jethwani G, Latthe P Myoinositol or D-chiro-inositol for PCOS symptoms in adolescents: a narrative review. J Pediatr Endocrinol Metab. 2023;37(2):91-101. doi: https://doi.org/10.1515/jpem-2023-0458Phelps D, Ward R, Williams R, et al. Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res. 2016;80(2):209-217. doi: https://doi.org/10.1038/pr.2016.97Phelps D, Ward R, Williams R, et al. Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res. 2016;80(2):209-217. doi: https://doi.org/10.1038/pr.2016.97Bizzarri M, Fuso A, Dinicola S, et al. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opin Drug Metab Toxicol. 2016;12(10):1181-1196. doi: https://doi.org/10.1080/17425255.2016.1206887Bizzarri M, Fuso A, Dinicola S, et al. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opin Drug Metab Toxicol. 2016;12(10):1181-1196. doi: https://doi.org/10.1080/17425255.2016.1206887DiNicolantonio JJ, H O'Keefe J. Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes. Open Heart. 2022;9(1):e001989. doi: https://doi.org/10.1136/openhrt-2022-001989DiNicolantonio JJ, H O'Keefe J. Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes. Open Heart. 2022;9(1):e001989. doi: https://doi.org/10.1136/openhrt-2022-001989Rojas J, Arraiz N, Aguirre M, et al. AMPK as Target for Intervention in Childhood and Adolescent Obesity. J Obes. 2011;2011:252817. doi: https://doi.org/10.1155/2011/252817Rojas J, Arraiz N, Aguirre M, et al. AMPK as Target for Intervention in Childhood and Adolescent Obesity. J Obes. 2011;2011:252817. doi: https://doi.org/10.1155/2011/252817Guo J, Chen H, Zhang X, et al. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev. 2021;2021:2074610. doi: https://doi.org/10.1155/2021/2074610Guo J, Chen H, Zhang X, et al. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev. 2021;2021:2074610. doi: https://doi.org/10.1155/2021/2074610Yang H, Seo SG, Shin SH, et al. 3,3-Diindolylmethane suppresses high-fat diet-induced obesity through inhibiting adipogenesis of pre-adipocytes by targeting USP2 activity. Mol Nutr Food Res. 2017;61(10). doi: https://doi.org/10.1002/mnfr.201700119Yang H, Seo SG, Shin SH, et al. 3,3-Diindolylmethane suppresses high-fat diet-induced obesity through inhibiting adipogenesis of pre-adipocytes by targeting USP2 activity. Mol Nutr Food Res. 2017;61(10). doi: https://doi.org/10.1002/mnfr.201700119Liu YF, Wang HH, Geng YH, et al. Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism. Front Pharmacol. 2023;14:1112088. doi: https://doi.org/10.3389/fphar.2023.1112088Liu YF, Wang HH, Geng YH, et al. Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism. Front Pharmacol. 2023;14:1112088. doi: https://doi.org/10.3389/fphar.2023.1112088Suciu I, Delp J, Gutbier S, et al. Definition of the Neurotoxicity- Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors. Antioxidants (Basel). 2023;13(1):49. doi: https://doi.org/10.3390/antiox13010049Suciu I, Delp J, Gutbier S, et al. Definition of the Neurotoxicity- Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors. Antioxidants (Basel). 2023;13(1):49. doi: https://doi.org/10.3390/antiox13010049Li Z, Wang Y Xu Q, et al. Berberine and health outcomes: An umbrella review. Phytother Res. 2023;37(5):2051-2066. doi: https://doi.org/10.1002/ptr.7806Li Z, Wang Y Xu Q, et al. Berberine and health outcomes: An umbrella review. Phytother Res. 2023;37(5):2051-2066. doi: https://doi.org/10.1002/ptr.7806Fogacci F, ALGhasab NS, Di Micoli V, et al. Cholesterol-Lowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety. Nutrients. 2024;16(10):1526. doi: https://doi.org/10.3390/nu16101526Fogacci F, ALGhasab NS, Di Micoli V, et al. CholesterolLowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety. Nutrients. 2024;16(10):1526. doi: https://doi.org/10.3390/nu16101526Xiong P Niu L, Talaei S, et al. The effect of berberine supplementation on obesity indices: A dose-response meta-analysis and systematic review of randomized controlled trials. Complement Ther Clin Pract. 2020;39:101113. doi: https://doi.org/10.1016/j.ctcp.2020.101113Xiong P Niu L, Talaei S, et al. The effect of berberine supplementation on obesity indices: A dose-response meta-analysis and systematic review of randomized controlled trials. Complement Ther Clin Pract. 2020;39:101113. doi: https://doi.org/10.1016/j.ctcp.2020.101113Ilyas Z, Perna S, Al-Thawadi S, et al. The effect of Berberine on weight loss in order to prevent obesity: A systematic review. Biomed Pharmacother. 2020;127:110137. doi: https://doi.org/10.1016/j.biopha.2020.110137Ilyas Z, Perna S, Al-Thawadi S, et al. The effect of Berberine on weight loss in order to prevent obesity: A systematic review. Biomed Pharmacother. 2020;127:110137. doi: https://doi.org/10.1016/j.biopha.2020.110137Zhang H, Wei J, Xue R, et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 2010;59(2):285-292. doi: https://doi.org/10.1016/j.metabol.2009.07.029Zhang H, Wei J, Xue R, et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 2010;59(2):285-292. doi: https://doi.org/10.1016/j.metabol.2009.07.029Yu M, Jin X, Liang C, et al. Berberine for diarrhea in children and adults: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2020;13:1756284820961299. doi: https://doi.org/10.1177/1756284820961299Yu M, Jin X, Liang C, et al. Berberine for diarrhea in children and adults: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2020;13:1756284820961299. doi: https://doi.org/10.1177/1756284820961299Wang H, Zhu C, Ying Y, et al. Metformin and berberine, two versatile drugs in treatment of common metabolic diseases. Oncotarget. 2017;9(11):10135-10146. doi: https://doi.org/10.18632/oncotarget.20807Wang H, Zhu C, Ying Y, et al. Metformin and berberine, two versatile drugs in treatment of common metabolic diseases. Oncotarget. 2017;9(11):10135-10146. doi: https://doi.org/10.18632/oncotarget.20807Malhotra B, Kulkarni GT, Dhiman N, et al. Recent advances on Berberis aristata emphasizing berberine alkaloid including phytochemistry, pharmacology and drug delivery system. J Herb Med. 2021;27:100433. doi: https://doi.org/10.1016/j.hermed.2021.100433Malhotra B, Kulkarni GT, Dhiman N, et al. Recent advances on Berberis aristata emphasizing berberine alkaloid including phytochemistry, pharmacology and drug delivery system. J Herb Med. 2021;27:100433. doi: https://doi.org/10.1016/j.hermed.2021.100433Amare DE. Anti-cancer and other biological effects of a dietary compound 3,3'-diindolylmethane supplementation: a systematic review of human clinical trials. Nutrition and Dietary Supplements. 2020;12:123-137. doi: https://doi.org/10.2147/NDS.S261577Amare DE. Anti-cancer and other biological effects of a dietary compound 3,3'-diindolylmethane supplementation: a systematic review of human clinical trials. Nutrition and Dietary Supplements. 2020;12:123-137. doi: https://doi.org/10.2147/NDS.S261577Hampl SE, Hassink SG, Skinner AC, et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics. 2023;151(2): e202206064. doi: https://doi.org/10.1542/peds.2022-060640Hampl SE, Hassink SG, Skinner AC, et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics. 2023;151(2): e202206064. doi: https://doi.org/10.1542/peds.2022-060640El Amrousy D, El-Afify D. Effects of alpha lipoic acid as a supplement in obese children and adolescents. Cytokine. 2020;130:155084. doi: https://doi.org/10.1016/j.cyto.2020.155084El Amrousy D, El-Afify D. Effects of alpha lipoic acid as a supplement in obese children and adolescents. Cytokine. 2020;130:155084. doi: https://doi.org/10.1016/j.cyto.2020.155084de Ligt M, Timmers S, Schrauwen P Resveratrol and obesity: Can resveratrol relieve metabolic disturbances? Biochim Biophys Acta. 2015;1852(6):1137-1144. doi: https://doi.org/10.1016/j.bbadis.2014.11.012de Ligt M, Timmers S, Schrauwen P Resveratrol and obesity: Can resveratrol relieve metabolic disturbances? Biochim Biophys Acta. 2015;1852(6):1137-1144. doi: https://doi.org/10.1016/j.bbadis.2014.11.012Hillsley A, Chin V, Li A, McLachlan CS. Resveratrol for Weight Loss in Obesity: An Assessment of Randomized Control Trial Designs in ClinicalTrials.gov. Nutrients. 2022;14(7):1424. doi: https://doi.org/10.3390/nu14071424Hillsley A, Chin V, Li A, McLachlan CS. Resveratrol for Weight Loss in Obesity: An Assessment of Randomized Control Trial Designs in ClinicalTrials.gov. Nutrients. 2022;14(7):1424. doi: https://doi.org/10.3390/nu14071424Xinmei Xu, Huan Yi, Jiasi Wu, et al. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomed Pharmacother. 2021;133:110984. doi: https://doi.org/10.1016/j.biopha.2020.110984Xinmei Xu, Huan Yi, Jiasi Wu, et al. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomed Pharmacother. 2021;133:110984. doi: https://doi.org/10.1016/j.biopha.2020.110984Mohammadpour S, Reza Amini M, Shahinfar H, et al. Effects of glucomannan supplementation on weight loss in overweight and obese adults: A systematic review and meta-analysis of randomized controlled trials. Obesity Medicine. 2020;19:100276. doi: https://doi.org/10.1016/j.obmed.2020.100276Mohammadpour S, Reza Amini M, Shahinfar H, et al. Effects of glucomannan supplementation on weight loss in overweight and obese adults: A systematic review and meta-analysis of randomized controlled trials. Obesity Medicine. 2020;19:100276. doi: https://doi.org/10.1016/j.obmed.2020.100276

The authors declare that there are no conflicts of interest present.